EkoHesap vs IVEX: Revenue, Funding & Team Size Compared
EkoHesap generates $710.3K in revenue; IVEX generates $693.6K. EkoHesap and IVEX are close to the same size by revenue. The table below compares EkoHesap and IVEX on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $710.3K | $693.6K |
| Valuation | $7.1M | $4.9M |
| Team size | 2 | 37 |
| Founded | 2017 | 2017 |
| HQ | Istanbul, Turkey | Heverlee, Belgium |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
EkoHesap at a glance
EkoHesap generates $710.3K in revenue with 2 employees, headquartered in Istanbul, Turkey.
- Revenue
- $710.3K
- Valuation
- $7.1M
- Team size
- 2
- Founded
- 2017
Developer of an online Saas software intended to simplify the accounting processes. The company's platform performs pre-accounting, financial, tax declarations, payroll, e-government transactions and depreciation, enabling micro SMEs and…
IVEX at a glance
IVEX generates $693.6K in revenue with 37 employees, headquartered in Heverlee, Belgium.
- Revenue
- $693.6K
- Valuation
- $4.9M
- Team size
- 37
- Founded
- 2017
Developer of a safety assessment tool and software designed to reduce traffic victims. The company's cloud-based tool assesses the safety of driven or simulated scenarios, reports on risk and safety key performance indicator and violations…
Other EkoHesap alternatives
EkoHesap competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
EkoHesap vs IVEX: frequently asked questions
Is EkoHesap or IVEX bigger?
EkoHesap is the bigger company by revenue, at $710.3K against $693.6K for IVEX.
How much revenue does EkoHesap make?
EkoHesap generates $710.3K in annual revenue with a team of 2.
How much revenue does IVEX make?
IVEX generates $693.6K in annual revenue with a team of 37.